Background In recent years, disease treatment has evolved strategies that require increase
in pharmaceutical agent's efficacy and selectivity while decreasing their toxicity in normal …

Over the last years, respiratory diseases represent a clinical concern, being included among
the leading causes of death in the world due to the lack of effective lung therapies, mainly …

Pulmonary drug delivery is a highly attractive topic for the treatment of infectious lung
diseases. Drug delivery via the pulmonary route offers unique advantages of no first-pass …

Cancer is the second largest cause of death worldwide with the number of new cancer
cases predicted to grow significantly in the next decades. Biotechnology and medicine can …

The design of smart drug delivery carriers has recently attracted great attention in the
biomedical field. Smart carriers can specifically respond to physical and chemical changes …

Idiopathic pulmonary fibrosis (IPF) is a chronic and diffuse form of interstitial lung disease of
unknown etiology with a fatal outcome. Although various strategies for IPF have been …

Metal‐organic frameworks (MOFs) are promising platforms for the synthesis of nanoparticles
for diverse medical applications. Their fundamental design principles allow for significant …

Over the past decade, the growing interest in targeted lung cancer therapy has guided
researchers toward the cutting edge of controlled drug delivery, particularly magnetic …

Cationic carbon dots were fabricated by pyrolysis of citric acid and bPEI25k under
microwave radiation. Various nanoparticles were produced in a 20–30% yield through …

Idiopathic pulmonary fibrosis (IPF) is a fibrotic interstitial lung disease in which collagen
progressively deposits in the supporting framework of the lungs. The pathological collagen …